JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio

Jan 14, 2020

|

SAN FRANCISCO – The 38th annual JP Morgan Healthcare Conference continued on Tuesday with diagnostics companies presenting before thousands of investors. Below are brief reports on the presentations and breakout sessions covered by our team at the conference.

Abbott Laboratories

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio

To read the full story....

Breaking News

Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK

Avacta, Cytiva Collaborate on Developing Coronavirus Rapid Test

Myriad Genetics Withdrawing FY2020 Financial Guidance Due to COVID-19 Pandemic

InBios International Gets FDA Emergency Use Authorization for SARS-CoV-2 Kit

COVID-19 Testing Drives 80 Percent Growth in GenMark Diagnostics Preliminary Q1 Revenues

Genetron Health Gets CE Mark for Coronavirus PCR Test

What's Popular?

FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

FDA Issues Emergency Use Authorization for Gnomegen Coronavirus Test

Bioneer Inks Deal With Qatar Petroleum to Supply Coronavirus Test Kits, Instruments

Thermo Fisher Preliminary Q1 Revenues up 1 to 2 Percent; Firm Withdraws 2020 Guidance

Sponsorships